Filing Flows › Akebia Therapeutics (AKBA) › Operating margin
Akebia Therapeutics (AKBA) operating margin by quarter
Akebia Therapeutics' operating margin was 7.6% in Q3 2025 (third quarter 2025), -15.0 pts from Q2 2025. Over the last 3 quarters it ranged from 7.6% (Q3 2025) to 23.6% (Q1 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2025 | 7.6% | -15.0 pts | — |
| Q2 2025 | 22.6% | -1.0 pts | — |
| Q1 2025 | 23.6% | — | — |
Q3 2025 at a glance
Akebia Therapeutics, Q3 2025: revenue $58.8M (+57% year over year), operating margin 7.6%, net earnings $540K, operating cash flow $28.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Akebia Therapeutics' operating margin?
Akebia Therapeutics' operating margin was 7.6% in Q3 2025 (third quarter 2025), -15.0 pts from Q2 2025.
How has Akebia Therapeutics' operating margin changed?
Over the last 3 quarters it ranged from 7.6% (Q3 2025) to 23.6% (Q1 2025).